High prevalence of ACE DD genotype among north Indian end stage renal disease patients

BMC Nephrology

Volumn 7, Issue , 2006, Pages

  Tripathi, Gaurav ^a   Dharmani, Poonam ^a   Khan, Faisal ^a   Sharma, R K ^a   Pandirikkal, Vinod ^a   Agrawal, Suraksha ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HUMAN; HYPERTENSION; INDIA; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR;

ADULT; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENTS; CASE-CONTROL STUDIES; CREATININE; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; INDIA; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PREVALENCE; RENIN-ANGIOTENSIN SYSTEM;

EID: 33750518569     PISSN: 14712369     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-7-15     Document Type: Article

References (44)

1. Guyton AC: Blood pressure control-special role of the kidneys and body fluids. Science 1991, 252:1813-1816.
2. Romero JC, Knox FG: Mechanism underlying pressure-related naturiuresis:the role of the rennin angiotensin and prostaglandin synthesis. State of art lecture. Hypertension 1988, 11:724-738.
3. Firth JD, Raine AEG, Ledingham JGG: The mechanism of pressure naturiuresis. J Hypertens 1990, 8:97-103.
4. Roman RJ, Cowley AW: Abnormal pressure-diuresis-naturiures response in spontaneous hypertensive rats. Am J Physiol 1985, 248:F199-F205.
5. Griffin KA, Bidani AK: Hypertensive renal damage: insights from animal models and clinical relevance. Curr Hypertens Res 2004, 6:145-153.
6. Levey AS: Nondiabetic kidney diseases. N Engl J Med 2002, 347:1505-1511.
7. El-Essawy AB, Berthoux P, Cecillon S, Deprele c, Thibaudin D, De Fillppis JP, Alamartine E, Berthoux F: Hypertension after renal transplantation and polymorphism of genes involved in essential hypertension: ACE, AGT, AT1R and ecNOS. Clin Nephrol 2002, 57:192-200.
8. Mondry A, Loh M, Liu P, Zhu AL, Nagel M: Polymorphism of the insertion/deletion ACE and M235T AGT genes and hypertension: surprising new finding and meta-analysis of data. BMC Nephrol 2005, 6:1.
9. Norris , Vaughan C: The role of rennin-angiotensin-aldosterone system in chronic kidney diseases. Expert Rev Cardiovac Ther 2003, 1:227-235.
10. Mayer G: ACE genotype and ACE inhibitor response in Kidney disease: a perspective. Am J Kidney Dis 2002, 40:227-235.
11. Michel MC, Bohner H, Koster J, Schafers RF, Hemann U: Safety of telmisartan in patients with arterial hypetension: an open-label, observational study. Drug Safety 2004, 27:334-335.
12. Ruggenenti P, Perna A, Gherardi G: Renoprotective properties of ACE inhibition in non-diabetic nephropathies with nonnephrotic proteinuria. Lancet 1999, 354:359-364.
13. Fernandez-Llama P, Poch E, Oriala J: Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis. Kidney Int 1998, 53:1743-1747.
14. Van Der Kleij FGH, De Jong PE, Henning RH, Zeeuw DD, Navis G: Enhanced response of blood pressure, renal function and aldosterone to angiotensin I in DD genotype are blunted by low sodium intake. J Am Soc Nephrol 2002, 13:1025-1033.
15. Redon J, Chaves FJ, Liao Y, Pascual JM, Rovira E, armengod ME, Cooper RS: Influence of the I/D polymorphism of the angiotensin-converting enzyme gene on the outcome of microalbuminuria in essential hypertension. Hypertension 2000, 35:490-495.
16. van Essen GG, Rensma PL, de Zeew D, Sluiter WJ, Scheffer H, Apperloo AJ, de Jong PE: Association between angiotensin converting enzyme gene polymorphism and failure of renoprotective therapy. Lancet 1996, 347:94-95.
17. Parving HH, Jacobson P, tarnow L, Rossing P, Poirier O, Cambien F: Effect of deletion polymorphism of angiotensin converting enzyme on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational followup study. BMJ 1996, 313:591-594.
18. Yudkin JS, Andres C, Mohamed AV, Gould M, Panahloo A, Haines AP, Humphries S, Talmud P: The angiotensin converting enzyme gene and angiotensin II type I receptor gene as a candidate genes for microalbuminuria: a study in nondiabetic and noninsulin dependent diabetic subjects. Arterioscl Thromb Vasc Biol 1997, 17:2188-2191.
19. Beige J, Schere S, weber A, Engeli S, offerman G, Opelz G, Distler A, Sharma AM: Angiotensin converting enzyme genotype and renal allograft survival. J Am Soc Nephrol 1997, 8:1319-1323.
20. Staessen JA, Wang JG, Ginocchio G, Petrov V, savendra AP, Soubrier F, Viletinck R, Fagard R: The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997, 15:1579-1592.
21. Comey CT, Koons BW, Presley KW, Smerick JB, Sobieralski CA, Stanley DM: DNA extraction strategies for amplified fragment length polymorphism analysis. J Forensic Sci 1994, 39:1254-69.
22. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346.
23. Dixit M, Mansur A, Dixit N, Gilman J, santarina L, Glicklich D: The role of ACE gene polymorphism in rapidity of progression of focal segmental glomerulosclerosis. J Postgrad Med 2002, 48:266-269.
24. Ray PE, Bruggeman LA, Horikoshi S, Aguilera G, Klotman PE: Angiotensin II stimulates human fetal mesanglial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors. Kidney Int 1994, 45:177-184.
25. Ruiz-Ortega M, Gomez-Garre D, Alcazar R, Palacios I, Bustos C, Gonzalez S: Involvement of angiotensin II and endothelin in matrix protein production and renal sclerosis. J hypertens 1994, 12:S51-S58.
26. Hunley TE, Julian BA, Phillips JA, Summar ML, Yoshida H, Horn RG: Angiotensin converting gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996, 49:571-577.
27. Mitch WE: Is the inherited ACE genotype a trump or a joker? J Clin Invest 1995, 96:2100-2101.
28. Lewis EJ, Hunsicker LG, bain RP, Rohde RD: The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. The collaborative study group. N Eng J Med 1993, 329:1456-1462.
29. Perez-Oller L, Torra R, Badenas C, Mila M, Darnall A: Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney diseases. Am J Kidney Dis 1999, 34:273-278.
30. van Dijk MA, Peters DJM, Breuning MH, Chang PC: The angiotensin converting enzyme genotype and microalbuminuria in autosomal dominant polycystic kidney. J Am Soc Nephrol 1999, 10:1916-1920.
31. Saggar-Malik AK, Afzal AR, Swissman JS, Bland M, Sagnella GA, Eastwood JB: Lack of association of ACE/angiotensinogen association genotype with renal function in autosomal dominant polycystic kidney disease. Genet Test 2000, 4:299-303.
32. Ecder T, Mcfann KK, Raynolds MV, Schrier RW: No effect of angiotensin-converting enzyme gene polymorphism on disease progression and left ventricular hypertrophy in autosomal dominant polycystic kidney disease. Am J Nephrol 2003, 23:466-470.
33. Lovati E, Richard A, Frey BM, Frey FJ, Ferrari P: Genetic polymorphism on the rennin-angiotensin-aldosterone system in endstage renal disease. Kidney Int 2001, 60:46-54.
34. Gumpretcht J, Zychma MJ: Angiotensin I converting enzyme gene insertion/deletion and angiotensinogin M235T polymorphisms: risk of CRF. Kidney Int 2000, 58:513-519.
35. McLaughlin KJ, Harden PN, Ueda S, Boulton-Jones JM, Connell JM, Jardine AG: The role of genetic polymorphisms of angiotensin-converting enzyme in the progression of renal diseases. Hypertension 1996, 28:912-915.
36. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F: Angiotensin Iconverting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993, 290:33-40.
37. Agrawal S, Khan S, Pandey A, Tripathi M, Herrera RJ: YAP, signature of an African-Middle Eastern migration into northern India. Curr Sci 2005, 88:1977-1980.
38. Palanichamy MG, Sun C, Agrawal S, Bandelt HJ, Kong QP, Khan F, Wang CY, Chaudhuri TK, Palla V, Zhang YP: Phylogeny of mitochondrial DNA macrohaplogroup N in India, based on complete sequencing: implications for the peopling of South Asia. Am J Hum Genet 2004, 75:966-978.
39. Agrawal S, Khan F: Reconstructing recent human phylogenies with forensic STR loci: a statistical approach. BMC Genet 2005, 28:47.
40. Agrawal S, Muller B, Bharadwaj U, Bhatnagar S, Sharma A, Khan F, Agarwal SS: Microsatellite variation at 24 STR loci in three endogamous groups of Uttar Pradesh, India. Hum Biol 2003, 75:97-104.
41. Kakinuma Y, Kawamura T, Bills T, Yoshioka T, Ichikawa I, Fogo A: Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int 1992, 42:46-55.
42. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993, 329:1456-1462.
43. Burg M, Menne J, Ostendorf T, Kliem V, Floege J: Gene-polymorphisms of angiotensin converting enzyme and endothelial nitric oxide synthase in patients with primary glomerulonephritis. Clin Nephrol 1997, 48:205-211.
44. van der Kleij FG, Navis GJ, Gansevoort RT, Heeg JE, Scheffer H, de Zeeuw D, de Jong PE: ACE polymorphism does not determine short-term renal response to ACE-inhibition in proteinuric patients. Nephrol Dial Transplant 1997, 12(Suppl 2):42-46.